Microbiology • Clinical and Diagnostic Microbiology

Culture-Based Identification

Growing microorganisms on selective and differential media remains the gold standard for pathogen identification in clinical laboratories.

Microbiology emblem with a microscope, test tubes, and DNA.
Inside this lesson 10 sections 5 questions 8 figures

SECTION 1

Historical Context & Motivation

Before the advent of modern molecular diagnostics, clinicians and researchers had no reliable way to determine which microorganism was causing a patient's infection. The idea that invisible living agents could cause disease—the germ theory of disease—was itself contentious for much of the nineteenth century, and proving it required a method to isolate and grow suspect organisms outside the human body. Culture-based identification arose from this need: by cultivating microorganisms on artificial media, researchers could observe colony morphology, biochemical behavior, and growth requirements, thereby linking a specific pathogen to a specific disease. Even today, when PCR and MALDI-TOF mass spectrometry dominate headlines, culture remains the reference standard for antibiotic susceptibility testing and for detecting novel or fastidious organisms that molecular panels may miss.

1876 • Koch Isolates Bacillus anthracis

Robert Koch demonstrated that Bacillus anthracis could be grown in pure culture and re-introduced to cause anthrax, establishing the template for linking a cultured organism to a specific disease.

1881 • Koch's Solid Media Revolution

Koch introduced gelatin-based solid media (later replaced by agar at the suggestion of Fanny Hesse) for isolating individual colonies, a breakthrough that made pure culture practical for clinical laboratories.

1882 • Koch's Postulates Formalized

Koch published his famous postulates, codifying the logical framework that requires isolation in pure culture as proof of causation—cementing culture as the cornerstone of diagnostic microbiology.

1928 • Fleming and Selective Culture

Alexander Fleming's observation that a Penicillium mold inhibited staphylococcal growth on an agar plate demonstrated that culture could reveal antimicrobial relationships, laying the groundwork for antibiotic susceptibility testing.

1960s–Present • Automated and Chromogenic Systems

The development of automated blood culture systems (e.g., BACTEC), chromogenic media, and miniaturized biochemical panels (API strips, Vitek) transformed culture from a purely manual art into a partially automated, standardized workflow integrated with informatics.

The central question that culture-based identification addresses is deceptively simple: Which organism is present in a clinical specimen, and what antimicrobial agents will kill or inhibit it? Answering that question reliably requires an understanding of growth media formulation, incubation conditions, colony morphology interpretation, and a battery of biochemical and serological tests—topics we will explore systematically in the sections that follow.

SECTION 2

Core Principles of Culture-Based Identification

Culture-based identification rests on several foundational principles that guide every step from specimen collection to final organism report. Understanding these principles clarifies why specific media are chosen, why incubation temperatures and atmospheres vary, and why a single colony type can yield a definitive identification through a cascade of phenotypic tests.

1

Pure Culture Isolation

A pure culture contains only one species. Streak-plate technique or serial dilution separates mixed flora so individual colonies arise from single cells, ensuring downstream tests reflect a single organism's phenotype.
2

Selective vs. Differential Media

Selective media contain inhibitors (e.g., bile salts, antibiotics) that suppress unwanted organisms, while differential media contain indicators (e.g., pH dyes, chromogenic substrates) that distinguish organisms by metabolic activity. Many media are both selective and differential.
3

Colony Morphology

Macroscopic features—size, shape (form), elevation, margin, texture, pigmentation, opacity, and hemolysis pattern—provide the first layer of presumptive identification and guide subsequent testing.
4

Biochemical Profiling

Enzyme activities (catalase, oxidase, coagulase, urease) and metabolic pathways (fermentation of specific sugars, citrate utilization, hydrogen sulfide production) generate a biotype code that is matched against a database for species-level identification.
5

Quality Control & Standardization

CLSI (Clinical and Laboratory Standards Institute) guidelines standardize inoculum density, incubation time/temperature, and reading criteria. Reference strains (e.g., E. coli ATCC 25922) validate media and reagent performance.
✦

KEY TAKEAWAY

Think of culture-based identification as a detective process analogous to forensic investigation at a crime scene. Just as a forensic team must first isolate each piece of evidence (pure culture), then analyze it with specialized instruments (biochemical tests), and finally match it against a database of known fingerprints (biotype codes), clinical microbiologists systematically narrow down a vast universe of possible organisms to a single species identification. The sequential, elimination-based logic is what gives culture its remarkable specificity—even if the process takes longer than molecular 'rapid tests.'

SECTION 3

Visual Overview: The Culture-Based Identification Workflow

The following diagram illustrates the complete workflow from clinical specimen receipt through final organism identification and susceptibility reporting. Each stage feeds into the next, and feedback loops (such as additional subcultures or repeat testing) may occur when results are ambiguous.

Culture-Based Identification WorkflowSpecimenCollection &TransportGram StainDirect SmearExaminationPrimary PlatingBAP, MAC, CHOCSelective/DifferentialIncubation35–37 °C, CO₂18–48 hColony MorphologySize, Color, HemolysisBiochemical TestsCatalase, Oxidase,Coagulase, TSI, etc.Automated IDVitek, API, MicroScanBiotype Code MatchingSpecies IdentificationDefinitive Organism ReportSusceptibility TestingKirby-Bauer, MIC,Automated ASTFinal Report to ClinicianOrganism + Antibiogram → Targeted TherapyTypical turnaround: 24–72 hours from specimen receipt
The workflow begins with specimen collection and Gram stain (upper left) and proceeds through primary plating, incubation, colony assessment, biochemical profiling, automated identification, and finally susceptibility testing before the clinician receives a definitive report. Note that the entire process typically requires 24–72 hours, which is both the strength (thoroughness) and limitation (turnaround time) of culture-based methods.

As the diagram illustrates, culture-based identification is a sequential, funnel-shaped process. The initial Gram stain provides a rapid preliminary classification—Gram-positive versus Gram-negative, cocci versus bacilli—that immediately narrows the differential and determines which media and tests follow. Primary plating on blood agar (BAP), MacConkey agar (MAC), and chocolate agar (CHOC) captures the broadest range of clinically significant organisms. After incubation, colony morphology acts as the first filter, guiding the technologist toward the appropriate biochemical panel. Automated identification systems like Vitek or API then match the biochemical profile to a species-level identification, and susceptibility testing determines which antibiotics the organism is sensitive or resistant to.

SECTION 4

How Culture Media Work: Mechanisms and Formulation

Culture media function by providing the essential nutrients—carbon sources, nitrogen sources, vitamins, minerals, and water—that microorganisms require for growth, while simultaneously creating conditions that favor or suppress specific taxa. The formulation of a medium determines which organisms will grow and how their metabolic activities become visible to the observer. Understanding the underlying biochemistry of media components is critical for interpreting culture results correctly.

Media Classification by Function

Media TypePurposeExamples
General PurposeSupport growth of a wide range of non-fastidious organisms without selectivity or differentiationNutrient agar, Tryptic soy agar (TSA)
EnrichedContain supplements (blood, serum, growth factors) to support fastidious organismsBlood agar (BAP), Chocolate agar (heated blood)
SelectiveContain inhibitory agents that suppress normal flora while allowing target pathogens to growMacConkey (bile salts, crystal violet), Mannitol salt (7.5% NaCl)
DifferentialContain indicators that produce visible color changes based on metabolic reactionsMacConkey (lactose + neutral red), Eosin methylene blue (EMB)
Enrichment (broth)Liquid media designed to amplify low numbers of a target organism from mixed specimens before subcultureSelenite broth (Salmonella), Thioglycolate broth (anaerobes)

Major categories of culture media used in clinical microbiology

Key Biochemical Reactions in Differential Media

Many differential media exploit simple enzymatic reactions. On MacConkey agar, lactose-fermenting organisms such as Escherichia coli produce acid end products that lower the local pH, causing the neutral red indicator to turn pink, yielding characteristic pink-to-red colonies. Non-lactose fermenters like Salmonella remain colorless or translucent. On blood agar, hemolytic enzymes (hemolysins) produced by organisms such as Streptococcus pyogenes lyse red blood cells, creating a clear zone (β-hemolysis), while partial lysis produces a greenish discoloration (α-hemolysis), and no lysis is termed γ-hemolysis.

Growth Kinetics and Incubation Parameters

BACTERIAL GROWTH (EXPONENTIAL PHASE)

N(t)=N0×2(t/g)N(t) = N₀ × 2^(t / g)

where N(t) = population at time t, N₀ = initial population, g = generation time (doubling time), and t = elapsed time. Typical generation times: E. coli ≈ 20 min, M. tuberculosis ≈ 15–20 h.

NUMBER OF GENERATIONS

n=t/g=(logN(t)−logN0)/log2n = t / g = (log N(t) − log N₀) / log 2

where n = number of generations (doublings). This equation is used to calculate how many doublings have occurred during a given incubation period and helps explain why slow-growing organisms (e.g., mycobacteria) require weeks of incubation to form visible colonies.

Standard clinical incubation is at 35–37 °C in ambient air or with 5–10% CO₂ supplementation (for capnophilic organisms like Neisseria and Haemophilus). Anaerobic organisms require incubation in an anaerobic jar or chamber with H₂ + CO₂ gas packs that remove O₂. Most routine cultures are examined at 18–24 hours and held for up to 48 hours; however, specialized cultures—blood cultures, mycobacterial cultures—may be incubated for 5 days to 8 weeks, respectively.

SECTION 5

Biochemical Testing and Identification Algorithms

After colony morphology and Gram stain of the isolate provide preliminary classification, a battery of biochemical tests narrows identification to the genus and species level. These tests exploit differences in enzymatic repertoires encoded in microbial genomes. The results are typically organized into branching identification algorithms or matched against numerical biotype databases.

Gram-Positive Cocci Identification AlgorithmGram-Positive CocciCatalase?+ (Positive)− (Negative)Staphylococcus spp.ClustersStreptococcus /EnterococcusCoagulase?+−S. aureusPATHOGENCoNSS. epidermidis, etc.Hemolysis?βαγGroup A/B StrepS. pyogenes / S. agalactiaeS. pneumoniaeOptochin +, Bile solubleEnterococcusPYR +, Bile esculin +Key Rapid TestsCatalase: H₂O₂ → bubblesCoagulase: clot formationPYR: hydrolysis of L-pyrrolidonylOptochin: zone ≥ 14 mmBacitracin: zone = sensitiveBile esculin: blackeningAlgorithm represents a simplified schema; additional tests (e.g., Lancefield grouping) may be needed
This decision tree shows the classic algorithm for identifying Gram-positive cocci. The catalase test is the primary branch point: catalase-positive organisms are staphylococci, and the coagulase test separates S. aureus from coagulase-negative staphylococci. Catalase-negative organisms are streptococci or enterococci, further differentiated by hemolysis pattern and additional rapid tests.

Common Biochemical Tests in Detail

TestPrinciplePositive ResultClinical Use
CatalaseDetects catalase enzyme that decomposes H₂O₂ into H₂O + O₂Immediate bubbling when H₂O₂ is applied to colonySeparates Staphylococcus (+) from Streptococcus (−)
CoagulaseDetects coagulase enzyme that converts fibrinogen to fibrinClot formation in rabbit plasma within 4 hoursIdentifies S. aureus (coagulase-positive)
OxidaseDetects cytochrome c oxidase in the electron transport chainDark purple color on reagent-impregnated paper within 10 secondsKey for Pseudomonas (+), separates from Enterobacterales (−)
TSI / KIATriple sugar iron agar detects glucose/lactose/sucrose fermentation and H₂S productionAcid (yellow) slant/butt, gas, black precipitateDifferentiates Enterobacterales: Salmonella, Shigella, E. coli
IndoleDetects tryptophanase enzyme that cleaves tryptophan to indoleRed ring with Kovac's reagentE. coli (+) vs. Klebsiella (−)
UreaseDetects urease that hydrolyzes urea to ammonia and CO₂Pink color change (pH increase) in urea brothProteus (+), Helicobacter pylori (rapid urease test)

Major biochemical tests used in culture-based identification

SECTION 6

Worked Example: Identifying an Unknown Isolate

A 54-year-old patient presents with a painful, erythematous wound infection following elective surgery. The clinical laboratory receives a wound swab. Let us walk through the culture-based identification process step by step.

Identifying a Wound Isolate

  1. 1

    Step 1 — Gram Stain of Direct Smear

    A direct Gram stain of the wound swab reveals abundant Gram-positive cocci in grape-like clusters amid polymorphonuclear leukocytes (PMNs), indicating an active bacterial infection. The clustering pattern is characteristic of staphylococci rather than streptococci (which typically form chains or pairs).
    Preliminary: Staphylococcus spp. suspected
  2. 2

    Step 2 — Primary Plating and Incubation

    The specimen is streaked for isolation on blood agar plate (BAP) and mannitol salt agar (MSA). Plates are incubated at 35 °C in ambient air for 18–24 hours.
    Media selected to isolate and differentiate staphylococci
  3. 3

    Step 3 — Colony Morphology Assessment

    After 24 hours, the BAP shows medium-sized, opaque, golden-yellow colonies surrounded by a zone of β-hemolysis (complete clearing of the blood). On MSA, the colonies are surrounded by a yellow halo, indicating mannitol fermentation (acid production turns the phenol red indicator yellow).
    β-hemolytic, mannitol-fermenting staphylococci → likely S. aureus
  4. 4

    Step 4 — Catalase Test

    A colony from BAP is transferred to a clean glass slide, and 3% hydrogen peroxide is applied. Immediate, vigorous bubbling is observed, confirming the organism is catalase-positive and belongs to genus Staphylococcus (as opposed to Streptococcus or Enterococcus, which are catalase-negative).
    Catalase: POSITIVE → Confirmed Staphylococcus
  5. 5

    Step 5 — Coagulase Test

    A tube coagulase test is performed by emulsifying colonies in rabbit plasma and incubating at 35 °C. At 4 hours, a firm clot is observed when the tube is tilted, indicating coagulase production. This enzyme converts fibrinogen to fibrin, a virulence mechanism that helps S. aureus evade phagocytosis.
    Coagulase: POSITIVE → Staphylococcus aureus confirmed
  6. 6

    Step 6 — Susceptibility Testing (Kirby-Bauer)

    A standardized inoculum (0.5 McFarland turbidity standard, ≈ 1.5 × 10⁸ CFU/mL) is prepared and lawn-streaked onto a Mueller-Hinton agar plate. Antibiotic disks including cefoxitin (a surrogate for oxacillin/methicillin resistance) are placed. After overnight incubation, the zone of inhibition around the cefoxitin disk measures 18 mm. According to CLSI breakpoints, a zone ≤ 21 mm for cefoxitin indicates methicillin-resistant S. aureus (MRSA).
    FINAL REPORT: MRSA — vancomycin recommended
ℹ

Clinical Significance

This example demonstrates why culture remains indispensable: not only did it identify the organism as S. aureus, but it also revealed methicillin resistance—information critical for selecting appropriate therapy. While rapid molecular tests (e.g., PCR for mecA gene) can detect MRSA in hours, culture provides a viable isolate for comprehensive susceptibility testing against dozens of antibiotics simultaneously.

SECTION 7

Strengths, Limitations, and Comparisons

Culture-based identification occupies a central but evolving position in the clinical microbiology laboratory. Its strengths are complemented by well-recognized limitations, and modern laboratories increasingly pair culture with molecular and proteomic methods. The following table provides a balanced assessment.

CriterionStrengthsLimitations
Turnaround TimeProvides viable organism for downstream testingTypically 24–72 h; mycobacteria may require weeks
SensitivityCan detect very low numbers of organisms if enrichment broth is used; gold standard for bloodstream infectionsSome organisms are unculturable (e.g., Treponema pallidum) or require special media (e.g., Legionella on BCYE)
SpecificityHigh—pure culture + biochemical profiling achieves species-level IDPhenotypic tests may fail for atypical strains or closely related species (e.g., S. pneumoniae vs. viridans group)
Susceptibility DataCulture is required for standardized AST; provides MIC values for all relevant antibioticsAST adds 18–24 h to turnaround; empiric therapy must begin before results
CostRelatively inexpensive per test; infrastructure widely availableLabor-intensive; skilled technologists required for interpretation
VersatilityCan detect unexpected or novel organisms not targeted by molecular panelsRequires foreknowledge to select appropriate media and incubation conditions

Strengths and limitations of culture-based identification

✦

KEY TAKEAWAY

Culture-based identification is like casting a wide net in the ocean: it can catch almost anything, including organisms you were not specifically looking for, but it requires patience while the net fills. Molecular methods, by contrast, are like fishing with a spear—fast and precise for known targets but blind to anything not in their sights. Modern clinical labs use both approaches synergistically: molecular tests for rapid preliminary results and culture for comprehensive susceptibility data and unexpected findings.

SECTION 8

Connection to Advanced and Molecular Methods

While culture-based identification remains foundational, the modern clinical laboratory increasingly integrates it with advanced technologies that reduce turnaround time and improve accuracy. Understanding how culture fits within this broader diagnostic ecosystem is essential for contemporary microbiologists.

FeatureCulture-Based IDMALDI-TOF MSMolecular (PCR/Sequencing)
Sample InputIsolated colony on agarIsolated colony (minutes of prep)DNA/RNA from specimen or colony
Time to Result24–72 h (includes growth)Minutes after colony available1–6 h (directly from specimen)
Provides AST?Yes—comprehensiveNo (ID only); requires culture for ASTLimited (detects specific resistance genes only)
Cost per Test$5–15 (media + reagents)$1–3 (after instrument purchase)$20–100+ (depending on panel)
Novel OrganismsCan detect—if media support growthCan identify if in database16S rRNA sequencing can identify novel species
Viable Organism Preserved?Yes—stored for further testingYes (colony remains on plate)No (nucleic acid extraction destroys cells)

Comparison of culture-based identification with MALDI-TOF mass spectrometry and molecular methods

The most transformative recent development has been MALDI-TOF mass spectrometry (Matrix-Assisted Laser Desorption/Ionization – Time of Flight), which can identify an organism from a single colony in under a minute by matching its protein mass fingerprint against a reference database. However, MALDI-TOF still requires a colony to begin with—meaning that culture remains the upstream step. Similarly, syndromic molecular panels (e.g., BioFire FilmArray) can detect dozens of pathogens directly from specimens in about an hour, but they test only for preprogrammed targets, cannot provide full susceptibility profiles, and do not preserve a viable isolate. The clinical microbiology laboratory of the future will likely continue to rely on culture as a complementary backbone, particularly for complex infections, epidemiological surveillance, and outbreak investigations.

💡

Looking Ahead

Emerging technologies like rapid phenotypic AST (which uses microfluidics or digital imaging to detect growth inhibition in hours rather than overnight) and metagenomic sequencing (which sequences all DNA in a specimen without culturing) may eventually reduce reliance on traditional culture. However, standardization, cost, and regulatory hurdles mean that culture-based methods will remain central to clinical microbiology for the foreseeable future.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

Explain the difference between selective and differential media. Can a single medium be both? Give an example and describe how it fulfills each function.
Show answer
Selective media contain agents (e.g., bile salts, high salt concentrations, antibiotics) that inhibit the growth of certain organisms while permitting others to grow. Differential media contain indicators—pH dyes, chromogenic substrates, or blood—that allow the observer to distinguish between organisms based on their metabolic activities. A medium can be both selective and differential. MacConkey agar is the classic example: it is selective because bile salts and crystal violet inhibit Gram-positive bacteria, and it is differential because it contains lactose and neutral red indicator, producing pink colonies for lactose fermenters (e.g., E. coli) and colorless colonies for non-lactose fermenters (e.g., Salmonella).

Question 2: BASIC CALCULATION

A single E. coli cell with a generation time of 20 minutes is deposited on a nutrient agar plate. How many cells will be present after 8 hours of incubation, assuming unlimited nutrients and no death? Express your answer in scientific notation.
Show answer
Using N(t) = N₀ × 2t/g2^{t/g}: N₀ = 1 cell, t = 8 h = 480 min, g = 20 min. Number of generations n = 480/20 = 24. Therefore N(480) = 1 × 2²⁴ = 16,777,216 ≈ 1.68 × 10⁷ cells. This exponential growth illustrates why a single bacterium deposited on agar can produce a visible colony (typically requiring ≈10⁶–10⁸ cells) within 18–24 hours. In practice, colonies become visible when the cell mass is large enough to scatter light, usually at around 10⁷ cells.

Question 3: INTERMEDIATE

A urine culture yields > 100,000 CFU/mL of a Gram-negative rod that produces pink colonies on MacConkey agar, is oxidase-negative, indole-positive, and produces gas from glucose. Which organism is most likely, and what is the clinical significance of the colony count?
Show answer
The organism is most likely Escherichia coli. The key evidence: (1) Gram-negative rod — consistent with Enterobacterales; (2) pink colonies on MacConkey — lactose fermenter; (3) oxidase-negative — rules out Pseudomonas and other non-fermenters; (4) indole-positive — E. coli produces tryptophanase, while Klebsiella (another lactose-fermenting GNR) does not; (5) gas from glucose — characteristic of E. coli. A colony count > 10⁵ CFU/mL from a clean-catch midstream urine is the classic Kass criterion for significant bacteriuria, indicating a urinary tract infection rather than contamination.

Question 4: APPLIED

A blood culture from a febrile patient flags positive after 14 hours. Gram stain of the broth shows Gram-positive cocci in chains. The organism grows on blood agar with β-hemolysis, is catalase-negative, PYR-positive, and hydrolyzes bile esculin. The Lancefield grouping is Group D. What is the most likely organism, and why is this identification clinically important for antibiotic selection?
Show answer
The most likely organism is Enterococcus faecalis. The evidence chain: Gram-positive cocci in chains (streptococci or enterococci), catalase-negative (excludes staphylococci), PYR-positive (enterococci and Group A Streptococcus are PYR-positive, but Group A is bacitracin-sensitive and typically β-hemolytic in younger patients), bile esculin hydrolysis positive (enterococci tolerate bile and hydrolyze esculin, producing a black precipitate), and Lancefield Group D antigen. This identification is clinically critical because enterococci are intrinsically resistant to cephalosporins and have low-level resistance to aminoglycosides. Empiric cephalosporin therapy, which would be appropriate for many other Gram-positive bacteremias, is ineffective against enterococci. Treatment typically requires ampicillin (if susceptible) or vancomycin, and susceptibility testing must also screen for vancomycin-resistant enterococci (VRE).

Question 5: CRITICAL THINKING

A patient with chronic cough and weight loss has three sputum specimens submitted for AFB (acid-fast bacilli) culture. The specimens are smear-negative (no AFB seen on Ziehl-Neelsen stain), but after 4 weeks of incubation on Löwenstein-Jensen medium, buff-colored, rough, dry colonies appear. The isolate is acid-fast positive and grows at 37 °C but not at 25 °C. Discuss why the smear was initially negative despite a positive culture, what organism is most likely, and why culture was essential in this case even though molecular methods (e.g., GeneXpert MTB/RIF) exist.
Show answer
The organism is most likely Mycobacterium tuberculosis. The smear was negative because acid-fast smear microscopy requires approximately 5,000–10,000 organisms per mL to be visible, giving it a sensitivity of only 50–80% compared to culture. Culture, which can detect as few as 10–100 viable organisms per mL, is significantly more sensitive and is considered the gold standard for tuberculosis diagnosis. The 4-week incubation is expected given the slow generation time of M. tuberculosis (approximately 15–20 hours). Colony morphology (buff, rough, dry, cord-forming) on LJ medium is characteristic. While GeneXpert MTB/RIF can detect M. tuberculosis DNA and rifampin resistance in about 2 hours, culture remains essential for several reasons: (1) it provides a viable isolate for comprehensive drug susceptibility testing against first- and second-line anti-TB drugs, which GeneXpert cannot do; (2) it confirms viability, distinguishing active infection from residual DNA; (3) culture isolates can be genotyped for epidemiological surveillance and outbreak investigation. This case underscores that culture and molecular methods are complementary, not competing, technologies.

SUMMARY

Summary: Culture-Based Identification

Summary

Culture-based identification is the foundational method in clinical microbiology for isolating, identifying, and determining the antimicrobial susceptibility of pathogenic microorganisms. The process begins with specimen collection and Gram staining, proceeds through primary plating on selective and differential media (such as blood agar, MacConkey agar, and chocolate agar), and continues with colony morphology assessment and a battery of biochemical tests (catalase, coagulase, oxidase, TSI, indole, urease) that generate a phenotypic profile matched to a species-level identification.

Key strengths of culture include its ability to detect unexpected or novel organisms, provide comprehensive antibiotic susceptibility testing (AST), and preserve a viable isolate for further investigation. Its primary limitation is turnaround time (24–72 hours or more), which modern laboratories address by integrating culture with rapid technologies such as MALDI-TOF mass spectrometry and molecular diagnostic panels. Despite these advances, culture-based identification remains the gold standard and an indispensable skill for every clinical microbiologist.

Varsity Tutors • Microbiology • Culture-Based Identification